Literature DB >> 17237554

Stem cells in the umbilical cord.

Mark L Weiss1, Deryl L Troyer.   

Abstract

Stem cells are the next frontier in medicine. Stem cells are thought to have great therapeutic and biotechnological potential. This will not only to replace damaged or dysfunctional cells, but also rescue them and/or deliver therapeutic proteins after they have been engineered to do so. Currently, ethical and scientific issues surround both embryonic and fetal stem cells and hinder their widespread implementation. In contrast, stem cells recovered postnatally from the umbilical cord, including the umbilical cord blood cells, amnion/placenta, umbilical cord vein, or umbilical cord matrix cells, are a readily available and inexpensive source of cells that are capable of forming many different cell types (i.e., they are "multipotent"). This review will focus on the umbilical cord-derived stem cells and compare those cells with adult bone marrow-derived mesenchymal stem cells.

Mesh:

Year:  2006        PMID: 17237554      PMCID: PMC3753204          DOI: 10.1007/s12015-006-0022-y

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  73 in total

1.  Neuro-glial differentiation of human bone marrow stem cells in vitro.

Authors:  P Bossolasco; L Cova; C Calzarossa; S G Rimoldi; C Borsotti; G Lambertenghi Deliliers; V Silani; D Soligo; E Polli
Journal:  Exp Neurol       Date:  2005-06       Impact factor: 5.330

2.  Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.

Authors:  Dörthe Schmidt; Anita Mol; Stefan Neuenschwander; Christian Breymann; Matthias Gössi; Gregor Zund; Marko Turina; Simon P Hoerstrup
Journal:  Eur J Cardiothorac Surg       Date:  2005-05       Impact factor: 4.191

3.  Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells.

Authors:  Gesine Kögler; Teja Falk Radke; Aurélie Lefort; Sandra Sensken; Johannes Fischer; Rüdiger V Sorg; Peter Wernet
Journal:  Exp Hematol       Date:  2005-05       Impact factor: 3.084

4.  Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury.

Authors:  Zhenhong Nan; Andrew Grande; Cyndy D Sanberg; Paul R Sanberg; Walter C Low
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

Review 5.  Oxygen in the cultivation of stem cells.

Authors:  Marie Csete
Journal:  Ann N Y Acad Sci       Date:  2005-05       Impact factor: 5.691

6.  Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?

Authors:  Kai Jaquet; Korff T Krause; Joachim Denschel; Patricia Faessler; Mona Nauerz; Stephan Geidel; Sigrid Boczor; Claudia Lange; Norbert Stute; Axel Zander; Karl-Heinz Kuck
Journal:  Stem Cells Dev       Date:  2005-06       Impact factor: 3.272

7.  Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction.

Authors:  Ryo Matsumoto; Takashi Omura; Minoru Yoshiyama; Tetsuya Hayashi; Sakiko Inamoto; Ki-Ryang Koh; Kensuke Ohta; Yasukatsu Izumi; Yasuhiro Nakamura; Kaname Akioka; Yasushi Kitaura; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

8.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

Authors:  Akira Nakamizo; Frank Marini; Toshiyuki Amano; Asadullah Khan; Matus Studeny; Joy Gumin; Julianne Chen; Stephen Hentschel; Giacomo Vecil; Jennifer Dembinski; Michael Andreeff; Frederick F Lang
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

9.  Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

Authors:  Hillard M Lazarus; Omer N Koc; Steven M Devine; Peter Curtin; Richard T Maziarz; H Kent Holland; Elizabeth J Shpall; Philip McCarthy; Kerry Atkinson; Brenda W Cooper; Stanton L Gerson; Mary J Laughlin; Fausto R Loberiza; Annemarie B Moseley; Andrea Bacigalupo
Journal:  Biol Blood Marrow Transplant       Date:  2005-05       Impact factor: 5.742

10.  Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.

Authors:  Katarina Le Blanc; Cecilia Götherström; Olle Ringdén; Moustapha Hassan; Robert McMahon; Edwin Horwitz; Göran Anneren; Ove Axelsson; Janice Nunn; Uwe Ewald; Solveig Nordén-Lindeberg; Monika Jansson; Ann Dalton; Eva Aström; Magnus Westgren
Journal:  Transplantation       Date:  2005-06-15       Impact factor: 4.939

View more
  111 in total

1.  Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.

Authors:  Ingrid Garzón; Barbara Pérez-Köhler; Juan Garrido-Gómez; Victor Carriel; Renato Nieto-Aguilar; Miguel Angel Martín-Piedra; Natalio García-Honduvilla; Julia Buján; Antonio Campos; Miguel Alaminos
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

2.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

Review 3.  Plasticity and maintenance of hematopoietic stem cells during development.

Authors:  Suman Kanji; Vincent J Pompili; Hiranmoy Das
Journal:  Recent Pat Biotechnol       Date:  2011-04

Review 4.  Regenerative medicine. Opportunities and challenges: a brief overview.

Authors:  Dame Julia Polak
Journal:  J R Soc Interface       Date:  2010-09-08       Impact factor: 4.118

Review 5.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

6.  Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.

Authors:  Chiyo Doi; Dharmendra Kumar Maurya; Marla M Pyle; Deryl Troyer; Masaaki Tamura
Journal:  Cytotherapy       Date:  2010-05       Impact factor: 5.414

Review 7.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

Review 8.  Very small embryonic-like stem cells: biology and therapeutic potential for heart repair.

Authors:  Ewa K Zuba-Surma; Wojciech Wojakowski; Mariusz Z Ratajczak; Buddhadeb Dawn
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

9.  Human umbilical cord mesenchymal stromal cells in a sandwich approach for osteochondral tissue engineering.

Authors:  Limin Wang; Liang Zhao; Michael S Detamore
Journal:  J Tissue Eng Regen Med       Date:  2010-12-30       Impact factor: 3.963

10.  Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood.

Authors:  N Mohanty; B R Gulati; R Kumar; S Gera; S Kumar; P Kumar; P S Yadav
Journal:  Cytotechnology       Date:  2014-12-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.